Abstract.
Ikaros is known as a critical regulator of lymphocyte development. We examined the regulatory role of Ikaros in LPS/IFN-γ-induced inducible nitric oxide synthase (iNOS) expression by macrophages. Our results showed that IK6 (Ikaros dominant negative isoform) induction increases the iNOS expression. Ikaros DNA binding activity on the iNOS promoter was decreased, and a mutation of the Ikaros-binding site on the iNOS promoter resulted in an increase in LPS/IFN-γ-induced iNOS expression. LPS/IFN-γ increased the histone (H3) acetylation on the Ikaros DNA binding site. These results suggest that Ikaros acts as a negative regulator on iNOS expression. Treatment with a casein kinase 2 (CK2) inhibitor reversed LPS/IFN-γ-induced decrease in Ikaros DNA binding activity. Moreover, overexpression of kinase-inactive CK2 decreased iNOS expression and a significant amount of CK2α1 translocated into the nucleus in LPS/IFN-γ-treated cells. Overall, these data indicate that LPS/IFN-γ decreases the Ikaros DNA binding activity via the CK2 pathway, resulting in an increase of iNOS expression.
Electronic supplementary material
The online version of this article (doi:10.1007/s00018-008-8332-7) contains supplementary material, which is available to authorized users.
Keywords. Ikaros, inducible nitric oxide synthase, casein kinase 2, macrophage, nitric oxide
Electronic Supplementary material
Footnotes
Received 14 June 2008; received after revision 3 August 2008; accepted 19 August 2008
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.